GLENMARK PHARMACEUTICALS INC., USA
美国进口商 · 进口 756 笔 · 主营 其他零售药品
美国 · 存续
756
进口笔数
0
出口笔数
$0
进口金额
$0
出口金额
2026-09-23
最近进口
—
最近出口
26
供应商数
0
采购商数
近 3 年贸易趋势
主营产品(HS 编码)
进口
| HS 编码 | 产品 |
|---|---|
| 300490 | 其他零售药品 |
| 300660 | 化学避孕药 |
| 300449 | 生物碱药品 |
| 300420 | 抗生素药品 |
| 300439 | 激素抗生素药品 |
| 294190 | 其他抗生素 |
| 701090 | 玻璃容器 |
| 300409 | 300409 |
| 300432 | 皮质类固醇药品 |
| 300440 | 300440 |
出口
暂无数据
主要市场
进口来源地
| 国家 / 地区 | 交易笔数 | 金额(USD) |
|---|---|---|
| 印度 | 753 | $0 |
| 西班牙 | 2 | $0 |
| 中国香港 | 1 | $0 |
出口目的地
暂无数据
贸易伙伴
上游供应商(共 26)
| 企业 | 国家 | 交易笔数 | 金额(USD) | 主营产品 |
|---|---|---|---|---|
| GLENMARK PHARMACEUTICALS LTD | 西班牙 | 300 | $0 | 其他零售药品、化学避孕药 |
| GLENMARK PHARMACEUTICALS LIMITED | 印度 | 284 | $0 | 其他零售药品、化学避孕药 |
| GLENMARK PHARMACEUTICALS LTD | 美国 | 85 | $0 | 其他零售药品、化学避孕药 |
| GLENMARK PHARMACEUTICALS LIMITED | 美国 | 28 | $0 | 其他零售药品、抗生素药品 |
| GLAND PHARMA LIMITED | 美国 | 19 | $0 | 其他零售药品、治疗呼吸装置 |
| ANTHEA PHARMA PRIVATE LIMITED | 印度 | 16 | $0 | 其他零售药品、其他诊断试剂 |
| MANKIND PHARMA LTD. | 印度 | 3 | $0 | 其他零售药品、抗生素药品 |
| PGP GLASS PRIVATE LIMITED | 印度 | 2 | $0 | 玻璃容器、塑料封口件 |
| Cyndea Pharma S.L. | 西班牙 | 2 | $0 | 其他零售药品、激素抗生素药品 |
| KAISHA PACKAGING PRIVATE LIMITED | 印度 | 2 | $0 | 贱金属盖、其他塑料包装制品 |
近期贸易明细
进口(共 756)
| 日期 | 产品 | 对手方 | 国家 | 金额(USD) |
|---|---|---|---|---|
| 2026-09-23 | 其他零售药品 | GLENMARK PHARMACEUTICALS LTD | 印度 | $0 |
| 2026-09-21 | 其他零售药品 | GLENMARK PHARMACEUTICALS LTD | 印度 | $0 |
| 2026-09-18 | 其他零售药品 | GLENMARK PHARMACEUTICALS LIMITED | 印度 | $0 |
| 2026-09-18 | PART OF FCL 7 PACKAGES 853 CARTONS PHARMACEUTICALS AS UNDER CETIRIZINE HCL TAB 10MG 14(FT) NDC CODE70677127901 FDA XXXXXXXXXXXX 61 X A A 45 H. T. S NO. 3004.90.9280 ANDA NO. 0 78427 THERAPEUTICE USE ANTIHISTAMINE CETIRIZINE HCL TAB 10MG 30 (FT) NDC CODE70677127902 FDA XXXXXXXXXXXX 61 X A A 45 H. T. S NO. 3004 .90.9280 ANDA NO. 078427 THERAPEUTICE USE ANTIHISTAMINE CETIRIZINE HCL TAB 10MG 90 (FT) NDC CODE70677127904 FDA XXXXXXXXXXXX 61 X A A 45 H. T. S NO. 3004.90.9280 ANDA NO. 078427 THERAPEUTICE USE ANTIHISTAMINE CETIRIZINE HCLTAB 10MG 365 NDC CODE72657012935 FDA XXXXXXXXO. 78427 THERAPEUTICE USE. ANTIHISTAMINE COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT. 30.08.2026 GROSS WT.1057.498 KGS NET WT.481.850 KGS 00 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX | GLENMARK PHARMACEUTICALS LIMITED | 印度 | $0 |
| 2026-09-18 | 15 PACKAGES 1183 CARTONS PHARMACEUTICALS AS UNDER LACOSAMIDE TAB 100MG 60 NDC CODE68462067960 FDA XXXXXXXXXXXX NO. 61 M C A 47 H. T. SNO. 3004.90.9230 ANDA NO. 205006 THERAPEUTIC E USE LACOSAMIDE TABLETS ARE INDICATED AS ADJUNCTIVE THERAPY IN THE TREATMENT OF XXXXXXXXXSET SEIZURES IN PATIENTS WITH EPILEPSY AGED 1 7 YEARS AND OLDER. LACOSAMIDE TAB 150MG 60 NDC CODE68462068060 FDA XXXXXXXXXXXX NO. 61 M C A 47 H. T. S NO. 3004.90.9230 ANDA NO. 205006 THERAPEUTICE USE LACOSAMIDE TABLETS ARE INDICATED AS ADJUNCTIVE THERAPY IN THE TREATMENT OF XXXXXXXXXXXX SEIZURES IN PATIENTS WITH EPILEPSY AGED 17 YEARS AND OLDER. LACOSAMIDE TAB 200MG 60 NDC CODE68462068160 FDA XXXXXXXX ANDA NO. 205006 THERAPEUTICE USE LACOSAMIDE TABLETS ARE INDICATED AS ADJUNCTIVE THERAPY IN THE TREATMENT OF XXXXXXXXXXXX SEIZURES IN PATIENTS WITH EPILEPSY AGED 17 YEARS AND OLDER. COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXX4 DT. 31.08.2026 GROSS WT.3601.966 KGS NET WT.2831.342 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 XXXXXXXXXXXXXXXXXXXXXXXXXXXX | GLENMARK PHARMACEUTICALS LTD | 印度 | $0 |
| 2026-09-18 | 40 PACKAGES 2070 CARTONS PHARMACEUTICALS AS UNDER NORGESTEE TAB 0.250.035MG 84 NDC CODE68462030929 FDA XXXXXXXXXXXX NO. 65 J D A 27 H.T. S NO. 3006.60.00.00 ANDA NO. 200538 THERA PEUTICE USE ORAL CONTRACEPTIVES ALYACEN 135TAB 10.035MG 84 NDC CODE68462039429 FDA PROD UCT CODE NO. 65 J D A 24 H. T. S NO. 3006.60. 00.00 ANDA NO. 091634 THERAPEUTICE USE ORALCONTRACEPTIVE ESTRADIOL VAG INSERTS 10MCG 8 NDC CODE68462071171 FDA XXXXXXXXXXXX NO. 64 G CA 28 H. T. S NO. 3006.60.00.00 ANDA NO.21026 4 THERAPEUTICE USETHE TREATMENT OF ATROPIC VAGINITIS DUE TO XXXXXXXXX. COMMERCIAL CUSTOMINVOICE NO. XXXXXXXXXXXX DT. 24.08.2026 F227 52002247 DT. 25.08.2026 F22752002255 DT. 25.0 8.2026 GROSS WT.6985.760 KGS NET WT.5341.900KGS 02 DATA LOGGERS SET TEMPERATURE 18 DE GREES SBILL NO 6217130 DT 24AUG2026 SBILL NO 6262396 DT 25AUG2026 XXXXXXXXXXXXXXXXXXXXXX | GLENMARK PHARMACEUTICALS LTD | 印度 | $0 |
| 2026-09-18 | PART OF FCL 6 PACKAGES 288 CARTONS PHARMACEUTICALS AS UNDER APREPITANT CAP 40MG 5UD NDC CODE68462058385 FDA XXXXXXXXXXXX NO. 61 T C E32 H. T. S NO. 3004.90.92.40 ANDA NO.207777 THERAPEUTICE USEAPREPITANT IS USED WITH OTHERMEDICATIONS TO HELP PREVENT NAUSEA AND VOMIT ING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHE RAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSEA AND VOMITING AFTER SURGERY. AEMETICNAUSEANT HUMAN RXSINGLE INGREDIENT DELAYED RELEASE TABLETS APREPITANT NITROGLYCERIN SUBLING TAB 0.6MG 100 NDC CODE68462064001 FDA PRODUCT CODE NO.66 S C A 28 H. T. S NO. 3004.90.9020 ANDA NO.206391 THERAPEUTICE USE MEDICATION USED FOR HEART FAILUREHIGH BLOOD PRESSUR EAND TO TREAT AND PREVENT CHEST PAIN FROM NOTENOUGH BLOOD FLOW TO THE HEART APREPITANT C AP 40MG 1UD NDC CODE68462058340 FDA PRODUCT CODE NO. 61 T C E 32 H. T. S NO. 3004.90.92.40ANDA NO. 207777 THERAPEUTICE USE APREPITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVENT NAUSEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHERAPY). THIS MEDICATION IS A LSO USED TO PREVENT NAUSEA AND VOMITING AFTERSURGERY. AEMETICNAUSEANT HUMAN RXSINGLE IN GREDIENT DELAYED RELEASE TABLETS APREPITANTAPREPITANT CAP 125MG 6UD NDC CODE6846205857 6 NDC NO.68462058576 FDA XXXXXXXXXXXX NO. 61 T C E 32 H. T. S NO. 3004.90.92.40 ANDA NO.207777 THERAPEUTICE USEAPREPITANT IS USED WITHOTHER MEDICATIONS TO HELP PREVENT NAUSEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CH EMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSEA AND VOMITING AFTER SURGERY. AEMETICNAUSEANT HUMAN RXSINGLE INGREDIENT DELAYED RELEASE TABLETS APREPITANT COMMERCIALCUSTOM INVOICE NO. XXXXXXXXXXXX DT. 30.08.2 026 F22787000811 DT. 30.08.2026 F22787000820 DT. 31.08.2026 F22787000822 DT. 31.08.2026 G ROSS WT.749.476 KGS NET WT.376.970 KGS SBILLNO 6467017 DT01SEP26 SBILL NO 6466847 DT01SE P26 SBILL NO 6466832 DT01SEP26 SBILL NO 6466838 DT01SEP26 06 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15DEGREES TO 25 DEGREES NOTIFY PARTY2 XXXXXXXXX | GLENMARK PHARMACEUTICALS LIMITED | 印度 | $0 |
| 2026-09-18 | 其他零售药品 | GLENMARK PHARMACEUTICALS LTD | 印度 | $0 |
| 2026-09-18 | 其他零售药品 | GLENMARK PHARMACEUTICALS LTD | 印度 | $0 |
| 2026-09-09 | PART OF FCL 6 PACKAGES 154 CARTONS PHARMACEUTICALS AS UNDER ESOMEPRAZOLE MAGNESIUM CAPSULES USP 20 MG (42C) OTC NDC NO. . 72657012442 FDA XXXXXXXXXXXX 62 T C F 06 ANDA NO. 216349 H. T. S NO. 3004.90.9260 COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXX DT. 24.08.2026 SBILL NO 6161079 DT22AUG26 GROSS WT.1385.880 K GS NET WT.73.137 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 DEGREES NOTIFY PARTY2XXXXXXXXXXXXXXXXXXXXXXXXX. USA XXXXXXXXXXXXXX | GRAVITI PHARMACEUTICALS PRIVATE LIM | 印度 | $0 |